Q2 FY26 results: revenue up 66% YoY, PAT more than doubles
JSLL · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.1 pts more than its Leisure Services peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Jeena Sikho Lifecare posted Q2 FY26 standalone revenue of Rs 189.85 cr, up 66% YoY from Rs 114.09 cr. PAT surged 121% to Rs 58.79 cr from Rs 26.60 cr; EPS at Rs 4.73 vs Rs 2.14. H1 FY26 revenue rose 70% to Rs 364.13 cr and PAT jumped 160% to Rs 110.10 cr. Both segments (ayurvedic trading and healthcare services) showed strong growth. Board also appointed Deepak K Garg and Associates as internal auditor for FY26. Prior period figures restated for Ind AS transition.
Strong double-digit growth across revenue and profit signals healthy momentum; likely positive for the stock.